Deutsche Bank analyst Emmanuel Papadakis downgraded Moderna to Hold from Buy with a $125 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRNA:
- Moderna (NASDAQ:MRNA) Expects Upbeat COVID-19 Vaccine Sales for 2023; Late Stage Pipeline Impresses
- Moderna director sells $1.81M in common stock
- William Blair to hold a webinar on initiation of coverage
- Merck, Moderna initiate Phase 3 study of V940 in combination with Keytruda
- Tesla downgraded, Netflix upgraded: Wall Street’s top analyst calls
Questions or Comments about the article? Write to editor@tipranks.com